For Investors

Stock Information

Emyria Limited (ASX:EMD ) is an Australian public company that commenced trading on the Australian Securities Exchange (ASX) on 12 February 2020, a data-backed, drug development company that elevates clinical care and delivers deeper clinical insights.

We see a global opportunity and believe that much of what we want to achieve today is already possible by bringing together the right talent and technology and staying caring, curious and courageous.

Reports

Annual Reports
Quarterly Reports

The future of healthcare is personalised medicine enabled by digital technology but configured in a way so we can learn as we go.

Call 1300 436 363Contact